When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Management of attention deficit hyperactivity disorder

   en.wikipedia.org/wiki/Management_of_attention...

   Atomoxetine, viloxazine, guanfacine, and clonidine are the only non-controlled, non-stimulant FDA approved drugs for the treatment of ADHD. [ citation needed ] Short-term clinical trials have shown medications to be effective for treating ADHD, but the trials usually use exclusion criteria, meaning knowledge of medications for ADHD is based on ...

3. List of investigational attention deficit hyperactivity ...

   en.wikipedia.org/wiki/List_of_investigational...

   This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...

4. Adult attention deficit hyperactivity disorder - Wikipedia

   en.wikipedia.org/wiki/Adult_attention_deficit...

   A 2025 meta-analytic systematic review of 113 randomized controlled trials demonstrated that stimulant medications significantly improved core ADHD symptoms in adults over a three-month period, with good acceptability compared to other pharmacological and non-pharmacological treatments. [45]

5. ADHD drugs' impact on brain health, quality of life ... - AOL

   www.aol.com/adhd-drugs-impact-brain-health...

   A study published in the American Journal of Psychiatry in September 2024 alarmingly found that high dose prescription amphetamines — which are stimulants and a first-line treatment for ADHD ...

6. Trigeminal nerve stimulation - Wikipedia

   en.wikipedia.org/wiki/Trigeminal_nerve_stimulation

   Trigeminal nerve stimulation (TNS) or external Trigeminal nerve stimulation (eTNS) is a non-invasive, non-medication therapy for Attention deficit hyperactivity disorder approved in the United States by the FDA for the treatment of ADHD in children ages 7–12. [1] [2] [3] It is also used off-label to treat ADHD in adults. [4]

7. Attention deficit hyperactivity disorder controversies

   en.wikipedia.org/wiki/Attention_deficit...

   Large, high quality research has found small differences in the brain between ADHD and non-ADHD patients. [1] [15] Jonathan Leo and David Cohen, critics who reject the characterization of ADHD as a disorder, contended in 2003 and 2004 that the controls for stimulant medication usage were inadequate in some lobar volumetric studies, which makes it impossible to determine whether ADHD itself or ...